Literature DB >> 14018309

In vitro studies of mammalian somatic cell variation. II. Isoimmune cytotoxicity with a cultured mouse lymphoma and selection of resistant variants.

H M CANN, L A HERZENBERG.   

Abstract

When long term cultures of mouse lymphoma cells, known to possess the isoantigenic phenotype determined by the H-2(d) allele, are incubated with anti H-2d isoantibody and guinea pig complement, slightly more than 99 per cent of cells are killed under optimal conditions. Growth in mass culture and colony formation by single cells after incubation with isoantibody and complement are employed to assess the cytotoxic effect. The cytotoxic action of isoantibody is complement-dependent, for viability of cells exposed to antibody alone is unaltered. When excess isoantibody and optimum concentrations of complement are used, killing begins as soon as these reagents are mixed with the cells, and no further killing occurs after 5 to 15 minutes at 37 degrees C. About 80 per cent of cells are killed with an isoantiserum containing antibody to two isoantigenic components of the H-2d complex. That the cytotoxic action is mediated through the H-2 isoantigen is shown by (a) isoantiserum containing only anti H-2d antibody produces maximal cell killing, and (b) isoantiserum from which anti H-2d antibody has been removed by absorption loses all cytotoxic activity. Variant cells resistant to the cytotoxic action of anti H-2d isoantibody were isolated from lymphoma cell populations surviving multiple exposures to isoantibody and complement. These variants can be distinguished morphologically from the isoantibody-sensitive parent cell line. Although variants are resistant to anti H-2d isoantibody, these cells possess H-2d isoantigen but in a lower concentration than found in cells of the parent line. The basis for resistance to cytotoxic isoantibody is discussed.

Entities:  

Keywords:  BLOOD GROUPS; GENETICS; LYMPHOMA; NEOPLASMS, EXPERIMENTAL; TISSUE CULTURE

Mesh:

Substances:

Year:  1963        PMID: 14018309      PMCID: PMC2137607          DOI: 10.1084/jem.117.2.267

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Genetics of human cell lines. II. Method for determination of mutation rates to drug resistance.

Authors:  W SZYBALSKI
Journal:  Exp Cell Res       Date:  1959-11       Impact factor: 3.905

2.  Histocompatibility genes of the mouse. II. Production and analysis of isogenic resistant lines.

Authors:  G D SNELL; R B JACKSON
Journal:  J Natl Cancer Inst       Date:  1958-11       Impact factor: 13.506

3.  The action of antibody and complement on mammalian cells.

Authors:  H GREEN; B GOLDBERG
Journal:  Ann N Y Acad Sci       Date:  1960-05-31       Impact factor: 5.691

4.  Association of H-2 antigens with the cell membrane fraction of mouse liver.

Authors:  L A HERZENBERG; L A HERZENBERG
Journal:  Proc Natl Acad Sci U S A       Date:  1961-06-15       Impact factor: 11.205

5.  Further studies on isoantigenic variation in mouse carcinomas and sarcomas.

Authors:  E KLEIN; G KLEIN; K E HELLSTROM
Journal:  J Natl Cancer Inst       Date:  1960-08       Impact factor: 13.506

6.  Serological differences between comparable diploid and tetraploid lines of three mouse ascites tumors.

Authors:  D B AMOS
Journal:  Ann N Y Acad Sci       Date:  1956-03-14       Impact factor: 5.691

7.  Immunoselection of polyploids from predominantly diploid cell populations.

Authors:  T S HAUSCHKA; B J KVEDAR; S T GRINNELL; D B AMOS
Journal:  Ann N Y Acad Sci       Date:  1956-03-14       Impact factor: 5.691

8.  Analysis of the histocompatibility-2 locus in the mouse.

Authors:  G D SNELL; P SMITH; F GABRIELSON
Journal:  J Natl Cancer Inst       Date:  1953-12       Impact factor: 13.506

9.  ESTIMATION OF MUTATION RATES WITH MAMMALIAN CELLS IN CULTURE.

Authors:  I Lieberman; P Ove
Journal:  Proc Natl Acad Sci U S A       Date:  1959-06       Impact factor: 11.205

10.  The distribution in the tissues and the development of H-2 antigens of the mouse.

Authors:  O PIZARRO; G HOECKER; P RUBINSTEIN; A RAMOS
Journal:  Proc Natl Acad Sci U S A       Date:  1961-12-15       Impact factor: 11.205

View more
  8 in total

1.  Abstracts of Papers Presented at the 1964 Meetings of the Genetics Society of America.

Authors: 
Journal:  Genetics       Date:  1964-08       Impact factor: 4.562

2.  Our NIH years: a confluence of beginnings.

Authors:  Leonore A Herzenberg; Leonard A Herzenberg
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

Review 3.  The early history of Stanford Immunology.

Authors:  Patricia P Jones; Leonore A Herzenberg
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

4.  Demonstration of a heterophile antigen on clone 929-L cells and their variant, Le cells, by an indirect fluorescent antibody technique.

Authors:  D R Wilson; S Fedoroff
Journal:  In Vitro       Date:  1972 Sep-Oct

5.  Colony formation by human fibroblasts: inhibition by multitransfusion and multiparous antisera.

Authors:  D A Pious
Journal:  Biochem Genet       Date:  1968-09       Impact factor: 1.890

6.  H-2 antigen expression: Loss in vitro, restoration in vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell line.

Authors:  O J Finn; M Lieberman; H S Kaplan
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

7.  H-2 Antigen variants in a cultured heterozygous mouse leukemia cell line : IV. Cell-Mediated cytolysis of wild type and variant cells.

Authors:  T V Rajan
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

8.  In vitro studies of mammalian somatic cell variation. I. Detection of H-2 phenotype in cultured mouse cell lines.

Authors:  H M CANN; L A HERZENBERG
Journal:  J Exp Med       Date:  1963-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.